Skip to main content
Have a personal or library account? Click to login
Percutaneous Embolization for Painful Varicocele: An 8-Year Tertiary Centre Experience Cover

Percutaneous Embolization for Painful Varicocele: An 8-Year Tertiary Centre Experience

Open Access
|Feb 2025

Figures & Tables

Figure 1

Fluoroscopy image showing selective catheterization of an insufficient left ISV during Valsalva manoeuvre before embolization (A), noting dilated veins in the pampiniform plexus (arrows) and the presence of a collateral vein (arrowheads). Fluoroscopy image showing a sandwich coil embolization at two levels of the left ISV (arrows) resulting in a complete stasis of contrast media at the proximal level (B).

Table 1

Laterality of varicocele and relative technical success rates.

LEFT‑SIDEDRIGHT‑SIDEDTOTAL
Number (n), (percentage [%])179 (77.92%)32 (22.08%)211 (100%)
Technical success, n (%)167 (93.27%)19 (59.37%)186 (88.15%)
Figure 2

Box and whisker plot for pain VAS before and after the intervention.

VAS = Visual Analog Scale.

Figure 3

Flow chart of patients who underwent varicocele embolization for scrotal pain.

Green = clinical success. Red = clinical failure.

Table 2

Mean values of duration of fluoroscopy, DAP and KERMA for the 71 interventions performed with coils and by right femoral access point.

DURATION OF FLUOROSCOPY (MIN)DAP (GY∙CM²)KERMA (MGY)
Median [IQR]17.1 [10, 24.3]43.1 [30.8, 94.1]130.4 [88.2, 254]
Mean ± SD20.3 ± 14.963.2 ± 50.5193.2 ± 173.6
Mean (95% CI)20.3 [17.1, 23.6]63.2 [52.1, 74.2]193.2 [155.3, 231.2]

[i] DAP = dose area product; KERMA = kinetic energy released per unit mass; IQR = interquartile range; SD = standard deviation; CI = confidence interval.

Table 3

Table summarizing different studies with employed embolic agents, venous access points, laterality of varicocele in patients and technical success rates.

STUDYEMBOLIC AGENT (N)VENOUS ACCESS POINTVARICOCELE LATERALITY (N)TECHNICAL SUCCESS RATE
Prasivoravong et al. [14] (2014)CoilsFemoralLeft (47)100%
Cantoro et al. [18] (2015)CoilsFemoralLeft (218)89%
Nabi et al. [19] (2003)CoilsFemoralLeft (50)
Right (15)
Bilateral (6)
96%
Shlansky‑Goldberg et al. [20] (1997)CoilsFemoral or jugularLeft (95)
Right (15)
Bilateral (63)
88%
Bilreiro et al. [21] (2017)Coils (103)
Glue (26)
FemoralLeft (129)99% (coils)
100% (glue)
Table 4

Table reviewing different studies of varicocele embolization, reporting clinical success or recurrence rates in patients referred for scrotal pain, with follow‑up durations and definitions of the studied entities.

STUDYFOLLOW‑UP DURATION (MONTHS)STUDIED ENTITYDEFINITIONRATE
Bilreiro et al. [21] (2017)10–36 (range)Clinical successComplete absence of symptoms4/6 (66.67%) for glue
30/34 (88.24%) for coils
RecurrenceDilated pampiniform plexus veins (calibre >3 mm) in a supine position with reflex (with/without Valsalva manoeuvre)3/26 (11.54%) for glue
6/103 (5.83%) for coils
Favard et al. [8] (2015)24.4 ± 17 (mean ± SD)Clinical successAbsence of reflux on Doppler ultrasound examination and/or absence of scrotal pain and heaviness depending on the initial indication83.9%
RecurrenceVaricocele which required a new endovascular or surgical repair7/63 (11%) for glue
7/53 (13.2%) for mechanical agents
4/66 (6%) for sclerosing agent
Puche‑Sanz et al. [6] (2014)39 (median)Clinical successPatients who completely improved or partially improved but appeared significantly satisfied86.9% for coils
RecurrencePersistence of venous reflux on ultrasonography13.1% for coils
Sheehan et al. [5] (2020)58 (median) (range, 28–106)RecurrenceRecurrence of testicular pain in the presence of a varicocele7/71 (16%) for glue and coils
DOI: https://doi.org/10.5334/jbsr.3769 | Journal eISSN: 2514-8281
Language: English
Submitted on: Sep 19, 2024
Accepted on: Jan 11, 2025
Published on: Feb 4, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Philippe Haroun, Salvatore Murgo, Georges Mjaess, Thierry Roumeguère, Fadi Tannouri, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.